One of the two major endocannabinoids, 2-arachidonoylglycerol (2-AG), serves as a retrograde messenger at various types of synapses throughout the brain. Upon postsynaptic activation, 2-AG is released immediately after de novo synthesis, activates presynaptic CB 1 cannabinoid receptors, and transiently suppresses neurotransmitter release. When CB 1 receptor activation is combined with some other factors such as presynaptic activity, the suppression is converted to a long-lasting form. Whereas 2-AG primarily transmits a rapid, transient, point-to-point retrograde signal, the other major endocannabinoid, anandamide, may function as a relatively slow retrograde or non-retrograde signal or as an agonist of the vanilloid receptor. The endocannabinoid system can be up-or down-regulated by a variety of physiological and environmental factors including stress, which might be clinically important.
Introduction
Endocannabinoids retrogradely modulate synaptic transmission widely throughout the central nervous system [1] [2] [3] [4] [5] . They are released from postsynaptic neurons, activate presynaptic CB 1 cannabinoid receptors, and suppress transmitter release either transiently (endocannabinoid-mediated short-term depression; eCB-STD) or persistently (endocannabinoid-mediated long-term depression; eCB-LTD). The eCB-STD and eCB-LTD are induced at various types of GABAergic and glutamatergic synapses throughout the brain. The ability of each synapse to express eCB-STD/LTD depends primarily on whether the presynaptic terminal expresses CB 1 receptors. In addition to their well-established functions as retrograde messengers, endocannabinoids might also function in non-retrograde manners [4] . In the last few years evidence has also accumulated to suggest that the endocannabinoid signaling system itself is regulated by various factors [6] . In this article, we review recent advances in the molecular mechanisms of endocannabinoid signaling and its plastic changes induced by neuromodulators and environmental factors.
Standard 2-AG model of eCB-STD
The molecular mechanisms of endocannabinoid release involved in eCB-STD have been studied in a variety of preparations. Here we show the standard 2-AG model ( Fig.   1 ), which can explain most, if not all, results of electrophysiological studies [1] [2] [3] [4] [5] . The conditions that induce the production and release of 2-AG are mechanistically classified into three types; increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ) (Ca 2+ -driven endocannabinoid release, CaER), activation of G q/11 -coupled receptors (basal receptor-driven endocannabinoid release, basal RER), and the combination of these two (Ca 2+ -assisted RER) [1, 2, 6] . After released from postsynaptic neurons, 2-AG activates presynaptic CB 1 receptors and suppresses transmitter release. Termination of the retrograde signal depends on degradation of 2-AG by monoacylglycerol lipase (MGL).
Although the expression of MGL is highly heterogeneous [7, 8] , 2-AG is degraded in a synapse non-specific manner by MGL concentrated in particular cell types [8] .
The CaER is responsible for the eCB-STD induced by depolarizing a postsynaptic neuron, which is termed DSI (depolarization-induced suppression of inhibition) or DSE (depolarization-induced suppression of excitation) for inhibitory or 
On-demand vs. pre-formed
It is generally thought that 2-AG is not stored in neurons, but synthesized on demand upon stimulation. However, this "on-demand synthesis model" was challenged by an alternative model that 2-AG is pre-formed by DGLα, pooled within cells, and mobilized from this hypothetical pre-formed 2-AG pools upon stimulation without the contribution of DGLα [18, 19] . This model was developed to reconcile the apparent discrepancy in the experimental results between genetic and pharmacological blockade of DGL. DGLα knockout mice were generated independently by three groups, and they all exhibit complete loss of eCB-STD [13] [14] [15] . In contrast, the reported effects of acute pharmacological blockade of DGL were highly controversial [19] . A classical DGL inhibitor, tetrahydrolipstatin (THL), inhibited eCB-STD in some studies, but not in others. Inconsistent results were also observed with a novel potent DGL inhibitor, OMDM-188. OMDM-188 failed to inhibit DSI in one study [20] , whereas it inhibited DSI but not mGluR-driven STD in another study [21] . More recently, however, effects of OMDM-188 on multiple types of eCB-STD including CaER, basal RER, Ca 2+ -assisted RER and synaptically-driven eCB release were systematically reexamined in acute slices of the hippocampus, cerebellum and striatum and in cultured hippocampal neurons [12] . The data clearly demonstrate that DSI, DSE, receptor-driven eCB-STD and synaptically-driven eCB-STD in these preparations are consistently blocked by the treatment with OMDM-188 [12] . Importantly, application of OMDM-188 as short as 2 min was sufficient to block DSI in cultured hippocampal neurons [12] . This study has confirmed that there is no discrepancy in the results between genetic and pharmacological blockade of DGL, supporting the "on-demand synthesis model" rather than the "pre-formed pool model".
Given that the "on-demand synthesis model" is correct, why were DGL inhibitors ineffective in blocking eCB-STD in some studies? One possibility is insufficient penetration of the inhibitors. Since THL and OMDM-188 are highly lipophilic, they are difficult to penetrate into brain slices. The effectiveness of these DGL inhibitors therefore depends on whether their targets (e.g., soma or dendrites) are located near the surface or in the depth of slices. The effectiveness of THL and OMDM-188 also depends on whether or not DGL activity is rate limiting for 2-AG production. If DGL activity is rate limiting for CaER, but not for RER, these two types of eCB-STD can have different sensitivity to the DGL inhibitors, as previously reported [21] . Whether the suppression of synaptic transmission by 2-AG is maximal or submaximal is also a key factor determining the effectiveness of DGL inhibitors. The inconsistent results of pharmacological studies might result from these differences. Although presynaptic mechanisms of eCB-LTD have not been fully elucidated, inhibition of the cAMP/PKA pathway seems to be crucial [4] . Involvement of calcineurin, RIM1α and Rab3 has also been suggested [4] . (Fig. 2 ). This associative feature may ensure the selective induction of eCB-LTD at the active synapses.
Standard 2-AG model of eCB-LTD

Contribution of anandamide to endocannabinoid signaling
The other major endocannabinoid, anandamide, also contributes to the modulation of synaptic transmission ( (Fig. 3A , eCB-LTD) and partly by activating postsynaptic TRPV1 channels (Fig. 3A , TRPV1-LTD) [32] . In the dentate gyrus, Chavez et al.
reported that pairing stimulation induces CB 1 -independent, TRPV1-dependent LTD, which is expressed postsynaptically and mediated by anandamide [33] . On the other hand, Puente et al. suggested that 2-AG mediates both eCB-STD and eCB-LTD in the striatum, whereas 2-AG and anandamide mediate eCB-STD and TRPV1-LTD, respectively, in the extended amygdala [34] . Anandamide may also generate the endocannabinoid tone (Fig. 3B ) which contributes to homeostatic plasticity in the hippocampus [36] and the regulation of hypothalamic-pituitary-adrenal (HPA) axis activity in the amygdala [37] Timing-dependent LTD at cortical excitatory synapses has been shown to require the activation of CB 1 receptors, which is believed to be located on presynaptic terminals (Fig. 2) . This hypothesis was challenged by a recent study, which suggested that the CB 1 receptors mediating LTD are not located on presynaptic terminals, but on perisynaptic astrocyte processes [41] . (3) Using mitochondrial fractions and anti-CB 1 polyclonal antibodies, it was shown that CB 1 receptors are expressed on mitochondrial membranes and are involved in the regulation of neuronal energy metabolism [43] .
However, these findings were questioned by a more recent study [47] , which has demonstrated that the previously used anti-CB 1 antibodies can bind to the mitochondrial protein stomatin-like protein 2, and the previously reported effects of cannabinoid agonist on mitochondrial respiration can be replicated in synaptosome-enriched, but not pure mitochondrial preparations. (4) FLAT was reported as a critical molecular component of anandamide transport in neural cells [44] . The study showed that FLAT is a catalytically silent splice variant of FAAH, is expressed robustly throughout the brain, and facilitates the translocation of anandamide into cells. A more recent study, however, suggested that FLAT does not serve as a global intracellular anandamide carrier [48] .
The study showed that the expression of FLAT is very low in the brain, and that overexpressed FLAT displays residual catalytic activity, suggesting that its capability to potentiate anandamide uptake may stem from its enzymatic rather than transport activity.
(5) A recent study using PLA 2 -knockout mice proposed that Ca 2+ elevation activates PLA 2 to liberate arachidonic acid which is then converted to 2-AG and induces DSE in cerebellar Purkinje cells [45] . However, since this result cannot be reconciled with the standard 2-AG model (Fig. 1A) that is supported by a large number of previous studies, further careful studies are required to judge the validity of the result.
Regulation and plasticity of the endocannabinoid system
The endocannabinoid system depends on many molecular elements, stress. There is growing evidence for functional interaction between the endocannabinoid system and activity along the HPA axis. The endocannabinoid system plays a key role in regulating the HPA axis under both basal and stressful conditions. It was proposed that a tonic level of anandamide within the basolateral amygdala provides a steady-state inhibition of HPA axis activity, and that glucocorticoid-induced 2-AG release from paraventricular nucleus neurons mediates rapid negative feedback effects of glucocorticoids on the HPA axis [37] . Conversely, stress-induced HPA axis activity alters the endocannabinoid system, either positively or negatively depending on the brain region, age and conditions of stress, in several brain regions including the hippocampus, amygdala, hypothalamus, nucleus accumbens and prefrontal cortex [6, 37, 51] . For example, repetitive immobilization stress impaired DSI/DSE by down-regulating CB 1 receptors in the paraventricular nucleus of the hypothalamus [52] , whereas chronic stress enhanced DSI partially by down-regulating MGL in the basolateral amygdala [53] . Interestingly, in vivo recordings of medial prefrontal cortex (mPFC)-evoked spike probability from the bed nucleus of the stria terminalis showed that acute restraint stress switched CB 1 -dependent plasticity from LTD to LTP, and that the stress-elicited shift in plasticity was controlled by CB 1 receptors on excitatory terminals [54] . Mechanisms of these stress-induced plastic changes in the endocannabinoid system remain to be elucidated.
A possible relationship between the endocannabinoid system and psychiatric disorders has also been suggested, by exploring genetic morphisms in the human genes for the CB 1 receptor and FAAH [55] , and by examining eCB-STD/LTD in animal models of psychiatric disorders including autism, schizophrenia and Fragile X syndrome [56] [57] [58] [59] [60] . In these animal models, alteration in DSI, mGluR-driven eCB-STD, eCB-LTD or the endocannabinoid tone has been reported. Further studies are required to understand the mechanisms that cause these alterations.
Conclusions
The endocannabinoid 2-AG plays an important role as a retrograde messenger at both excitatory and inhibitory synapses. It is synthesized and released from postsynaptic neurons in an activity-dependent manner, and suppresses transmitter release transiently (eCB-STD) or persistently (eCB-LTD). Although considerable progress has been made in recent years with regard to the molecular mechanisms of eCB-STD and eCB-LTD, several questions remain unsolved. First, the enzyme that produces DG upon Ca This study demonstrates that MGL is present only in particular types of presynaptic terminals, yet eCB-STD is prolonged rather non-selectively at both MGL-positive and MGL-negative synapses in the cerebellum of MGL knockout mice. This study also
shows that MGL expressed in astroglia significantly contributes to 2-AG degradation, because eCB-STD is prolonged in the cerebellum of conditional MGL knockout mice in which MGL is expressed only in astroglia.
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